Trial Profile
Pharmacokinetics of Tenofovir in Blood, Plasma and Urine of Healthy Adults With Perfect, Median and Low Drug Adherence
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms TARGET
- 21 Apr 2021 Results (n=36) assessing urine tenofovir levels among individuals taking tenofovir alafenamide at variable dosing intervals, and compare them to a prior study of directly observed therapy tenofovir disoproxil fumarate, presented at the 28th Conference on Retroviruses and Opportunistic Infections.
- 17 Jul 2019 Results to estimate the correlation between urine and plasma TFV concentrations in a randomized directly-observed pharmacokinetic study published in the Clinical Infectious Diseases
- 21 Mar 2018 Status changed from recruiting to completed.